YU47746B - Postupak za dobijanje novih preparata - Google Patents

Postupak za dobijanje novih preparata

Info

Publication number
YU47746B
YU47746B YU117890A YU117890A YU47746B YU 47746 B YU47746 B YU 47746B YU 117890 A YU117890 A YU 117890A YU 117890 A YU117890 A YU 117890A YU 47746 B YU47746 B YU 47746B
Authority
YU
Yugoslavia
Prior art keywords
organic anions
procedure
compsn
obtaining new
cpd
Prior art date
Application number
YU117890A
Other languages
English (en)
Other versions
YU117890A (sh
Inventor
R.G. Markham
Original Assignee
Oxycal Laboratories Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/246,504 external-priority patent/US4968716A/en
Application filed by Oxycal Laboratories Inc. filed Critical Oxycal Laboratories Inc.
Publication of YU117890A publication Critical patent/YU117890A/sh
Publication of YU47746B publication Critical patent/YU47746B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

POSTUPAK ZA DOBIJANJE NOVIH PREPARATA naznačen time, što se meša a) terapeutski aktivno jedinjenje koje ima i) molekulsku masu ispod 5000, ii) kiselu funkcionalnu grupu i pKa = 6 nafiziološkom pH=7,4 i b) bar jedno jedinjenje odabrano iz grupe koju čine L-treonska, L-ksilonska i L-liksonska kiselina i jestive njihove netoksične aldono-laktonske i aldono-laktidne soli. Prijava sadrži još 1 zavisan zahtev.
YU117890A 1988-09-19 1990-06-15 Postupak za dobijanje novih preparata YU47746B (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/246,504 US4968716A (en) 1987-04-10 1988-09-19 Compositions and methods for administering therapeutically active compounds
PCT/US1989/004046 WO1990003167A1 (en) 1988-09-19 1989-09-15 Compositions and methods for administering therapeutically active compounds

Publications (2)

Publication Number Publication Date
YU117890A YU117890A (sh) 1993-10-20
YU47746B true YU47746B (sh) 1996-01-08

Family

ID=22930954

Family Applications (1)

Application Number Title Priority Date Filing Date
YU117890A YU47746B (sh) 1988-09-19 1990-06-15 Postupak za dobijanje novih preparata

Country Status (16)

Country Link
EP (1) EP0417209B1 (sh)
JP (1) JP2973365B2 (sh)
AT (1) ATE160939T1 (sh)
CA (1) CA1341434C (sh)
DE (1) DE68928488T2 (sh)
DK (1) DK175783B1 (sh)
FI (1) FI97950C (sh)
HU (1) HU905911D0 (sh)
NO (1) NO178056C (sh)
NZ (1) NZ230700A (sh)
PL (1) PL165416B1 (sh)
RO (1) RO108148B1 (sh)
RU (1) RU2059410C1 (sh)
WO (1) WO1990003167A1 (sh)
YU (1) YU47746B (sh)
ZA (1) ZA904494B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1124550B9 (en) * 1999-08-30 2008-11-05 The Ester C Company Uses and compositions for selective cancer chemotherapy
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
FI20095278A0 (fi) 2009-03-18 2009-03-18 Valtion Teknillinen Ksylonihapon valmistus
KR101037125B1 (ko) * 2009-05-14 2011-05-26 계명대학교 산학협력단 바이오에탄올 생산을 위한 바이오매스 전처리법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606903A (en) * 1944-03-29 1952-08-12 Physiological Chemicals Compan Ascorbic acid addition compound of sulfathiazole
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
GB2040164A (en) * 1979-01-31 1980-08-28 Beecham Group Ltd Compositions containing paracetamol
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C

Also Published As

Publication number Publication date
YU117890A (sh) 1993-10-20
DE68928488T2 (de) 1998-04-02
NO902132L (no) 1990-05-14
DE68928488D1 (de) 1998-01-22
DK124290D0 (da) 1990-05-18
NO902132D0 (no) 1990-05-14
NO178056B (no) 1995-10-09
NZ230700A (en) 1992-07-28
EP0417209A1 (en) 1991-03-20
JP2973365B2 (ja) 1999-11-08
ZA904494B (en) 1991-03-27
FI97950C (fi) 1997-03-25
RO108148B1 (ro) 1994-02-28
NO178056C (no) 1996-01-17
DK124290A (da) 1990-05-18
EP0417209B1 (en) 1997-12-10
HU905911D0 (en) 1991-03-28
FI97950B (fi) 1996-12-13
FI902461A0 (fi) 1990-05-18
WO1990003167A1 (en) 1990-04-05
DK175783B1 (da) 2005-02-21
CA1341434C (en) 2003-07-08
AU621672B2 (en) 1992-03-19
EP0417209A4 (en) 1992-01-08
ATE160939T1 (de) 1997-12-15
JPH03504502A (ja) 1991-10-03
AU4328889A (en) 1990-04-18
RU2059410C1 (ru) 1996-05-10
PL165416B1 (pl) 1994-12-30

Similar Documents

Publication Publication Date Title
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
AU8091787A (en) The use of paroxetine to treat pain
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
NO930893D0 (no) Ultralydformidlet administrering av forbindelser i akvatiske dyr
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
DE3687255D1 (de) Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
YU117890A (sh) Postupak za dobijanje novih preparata
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
FR2547814B1 (fr) Derives de l'acide bicyclo (3.2.1.) octane carboxylique, leur procede de preparation et leur application therapeutique
DE3276786D1 (en) Medical process and preparation
Baxter Effects of tumor necrosis factor on in vitro digital arterial responses in horses
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
ES2009239A6 (es) Metodo para preparar una composicion liquida y un unguento topico para el tratamiento de heridas abiertas en el tejido humano.
IT8464501A0 (it) Procedimento ed impianto per il trattamento di carniccio di conceria per recuperare le frazioni riutilizzabili come grasso, proteine, sali inorganici, acque alcalino solfuree per riduzione scleroproteine.
RU98111356A (ru) Способ лечения ожогового шока